✦ LIBER ✦

Investigation of the eIF2α phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells

✍ Scribed by Azmi Yerlikaya; Harun Dokudur

Book ID: 110174852
Publisher: SP MAIK Nauka/Interperiodica
Year: 2010
Tongue: English
Weight: 533 KB
Volume: 44
Category: Article
ISSN: 0026-8933
DOI: 10.1134/s0026893310050122

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docosahexaenoic acid induces proteasome-

Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor α and inhibits the downstream signaling target in MCF-7 breast cancer cells

✍ I-Fen Lu; Ann-Che Hasio; Meng-Chun Hu; Feng-Ming Yang; Hui-Min Su 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 717 KB

Prolactin and estradiol utilize distinct

Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor α in T47D breast cancer cells

✍ YenHao Chen; KuangTzu Huang; KuanHui E. Chen; Ameae M. Walker 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 448 KB

Inhibition of apoptosis in human breast

Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic state

✍ Yolanda Fernández; Bin Gu; Antonio Martínez; Angels Torregrosa; Angels Sierra 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 734 KB

Reduction in apoptosis has been associated with tumor metastases and response to chemotherapy in breast cancer. We examine the influence of apoptosis status and the expression of antiapoptotic proteins Bcl-2 and Bcl-x(L) on metastatic progression and response to therapy in an experimental model of b

Inhibition of focal adhesion kinase supp

Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells

✍ Stephen Hiscox; Peter Barnfather; Edd Hayes; Pamela Bramble; James Christensen; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 559 KB

Roscovitine, a selective CDK inhibitor,

Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells

✍ Józefa Węsierska-Gądek; David Gritsch; Nora Zulehner; Oxana Komina; Margarita Ma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB

## Abstract Roscovitine (ROSC), a selective cyclin‐dependent kinase (CDK) inhibitor, arrests human estrogen receptor‐α (ER‐α) positive MCF‐7 breast cancer cells in the G~2~ phase of the cell cycle and concomitantly induces apoptosis __via__ a p53‐dependent pathway. The effect of ROSC is markedly di

Identification of PUMA as an estrogen ta

Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer

✍ Roberts, C G; Millar, E K A; O'Toole, S A; McNeil, C M; Lehrbach, G M; Pinese, M 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 810 KB